Veradermics MANE
NYSE MANE
$148.63 +4.68 (+3.25%)
As of: Nov 10, 2026 · 3:59 PM EST

Veradermics (MANE) Non Operating Income (2025 - 2026)

Updated

Veradermics (MANE) recorded Non Operating Income of $6.05 million in Q2 2026, compared with $428,000 a year earlier and up 130.1% from the prior quarter.

Analysis

Veradermics (MANE) Non Operating Income (2025 - 2026) Analysis & Trends

On a TTM basis, Veradermics' Non Operating Income came in at $9.62 million as of Jun 30, 2026; for FY2025, it came in at $2.35 million, up 711.0% from FY2024.

  • Across earlier years, Non Operating Income came in at $290,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -130.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Veradermics 6.01 Bn 4.61 Bn - 6.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.05 Mn
Mar 31, 2026 2.63 Mn
Jun 30, 2025 428,000.00
Mar 31, 2025 515,000.00
API Access

Veradermics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=MANE&period=max&api_key=YOUR_API_KEY